IP Library Granted Patent US 7,317,099
Granted Patent B2
US 7,317,099 · App. 10/168,365 · Granted Jan 8, 2008

Polynucleotides encoding stem cell growth factor-like polypeptides

Assignee: Kirin Pharma Kabushiki Kaisha
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,317,099
App. No.
10/168,365
Granted
Jan 8, 2008
Kind
B2
Abstract

The invention provides novel polynucleotides and polypeptides encoded by such polynucleotides and mutants or variants thereof that correspond to a novel human secreted stem cell growth factor-like polypeptide. These polynucleotides comprise nucleic acid sequences isolated from cDNA libraries prepared from human fetal liver spleen, ovary, adult brain, lung tumor, spinal cord, cervix, ovary, endothelial cells, umbilical cord, lymphocyte, lung fibroblast, fetal brain, and testis. Other aspects of the invention include vectors containing processes for producing novel human secreted stem cell growth factor-like polypeptides, and antibodies specific for such polypeptides.

Claims (26)

1. An isolated polynucleotide encoding a polypeptide comprising the amino acid sequence of SEQ ID NO:25 or encoding a polypeptide with stem cell growth factor activity comprising a sequence of amino acids having at least 99% sequence identity with the amino acid sequence of SEQ ID NO:25.

2. A vector comprising the polynucleotide of claim 1 .

3. An expression vector comprising the polynucleotide of claim 1 .

4. An isolated host cell genetically engineered to express the polynucleotide of claim 1 .

5. The polynucleotide of claim 1 , wherein the polynucleotide encodes the polypeptide of SEQ ID NO:25.

6. A vector comprising the polynucleotide of claim 5 .

7. An expression vector comprising the polynucleotide of claim 5 .

8. An isolated host cell genetically engineered to express the polynucleotide of claim 5 .

9. An isolated polynucleotide selected from the group consisting of:

(a) a polynucleotide comprising the nucleotide sequence of SEQ ID NO: 24;

(b) a polynucleotide comprising the nucleotide sequence of SEQ ID NO: 26; and

(c) a polynucleotide comprising the nucleotide sequence of SEQ ID NO: 29.

10. The polynucleotide of claim 9 which is a DNA sequence.

11. An isolated polynucleotide which comprises the complement of the polynucleotide of claim 9 .

12. A vector comprising the polynucleotide of claim 9 .

13. An expression vector comprising the polynucleotide of claim 9 .

14. An isolated host cell genetically engineered to express the polynucleotide of claim 9 .

15. The host cell of claim 14 wherein the polynucleotide is present in a plasmid and is in operative association with a regulatory sequence that controls expression of the polynucleotide in the host cell.

16. An isolated polynucleotide consisting of the nucleotide sequence of SEQ ID NO:24.

17. The polynucleotide of claim 16 which is a DNA sequence.

18. An isolated polynucleotide which consists of the complement of the polynucleotide of claim 16 .

19. An isolated polynucleotide comprising a coding sequence, wherein the coding sequence encodes a polypeptide consisting of the amino acid sequence of SEQ ID NO:25.

20. A vector comprising the polynucleotide of claim 19 .

21. An expression vector comprising the polynucleotide of claim 19 .

22. An isolated host cell genetically engineered to express the polynucleotide of claim 19 .

23. The host cell of claim 22 wherein the polynucleotide is present in a plasmid and is in operative association with a regulatory sequence that controls expression of the polynucleotide in the host cell.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE NATURE OF CONVEYANCE AND ASSIGNOR'S NAME PREVIOUSLY RECORDED ON REEL 022390 FRAME 0234. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded May 26, 2021
From: KYOWA HAKKO KOGYO CO., LTD.
To: KYOWA HAKKO KIRIN CO., LTD.
Reel/Frame 056583/0647 →
MERGER Recorded Mar 13, 2009
From: KIRIN PHARMA CO., LTD.
To: KYOWA HAKKO KIRIN CO., LTD.
Reel/Frame 022390/0234 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2007
From: NUVELO, INC.
To: KIRIN PHARMA KABUSHIKI KAISHA
Reel/Frame 020134/0948 →
MERGER Recorded Nov 11, 2005
From: VARIAGENICS, INC.; HYSEQ, INC.
To: NUVELO, INC.
Reel/Frame 017241/0784 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 11, 2003
From: LIU, CHENGHUA; LABAT, IVAN; TANG, Y. TOM; DRMANAC, RADOJE T.; CHAO, CHENG-CHI; LEE, JUHI; MIZE, NANCY K.; CHILDS, JOHN
To: HYSEO, INC. (A NEVADA CORPORATION)
Reel/Frame 013865/0035 →
Continuity (7)
Continuation In Part 0954735800 · Apr 11, 2000
Continuation In Part 0954571400 · Apr 7, 2000
Continuation In Part 0948872500 · Jan 21, 2000
Continuation In Part 0947127500 · Dec 23, 1999
Continuation In Part 0954571400 · Apr 7, 2000
Continuation In Part 0948872500 · Jan 21, 2000
Related Publication 20030211987A1 · Nov 13, 2003